Posts Tagged ‘companion diagnostics’

20% Of New Drugs In The U.S. Last Year Were Personalized Meds

  While pharmaceutical companies are still trying to figure out whether they should partner with companion diagnostic makers, acquire them, or simply begin developing their own tests, one thing remains certain: companion diagnostics are here to stay. 

Companion Diagnostics and Pharmaceuticals: Tying The Knot

  I recently read an article, The Future of Cancer Treatment Is (Almost) Here, which discusses liquid biopsy, a method of using blood samples to detect cancer. While new forms of cancer detection and monitoring continue to be developed, we’ve already made significant strides in the treatment of certain diseases.